Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

Asuragen announce the launch of AmplideX PCR/CE DMPK Kit for myotonic dystrophy

Products are for professional/laboratory use only.

Abacus dx would like to update you with the latest products from Asuragen.

Asuragen have recently announced the launch of AmplideX® PCR/CE DMPK. This kit aims to simplify the analysis of repeat expansions within the DMPK gene, which is implicated in myotonic dystrophy type 1 (DM1).
 
As part of our release of AmplideX® PCR/CE DMPK into the ANZ market, Abacus dx would like your help and feedback on this product and use in the diagnosis of myotonic dystrophy type 1.

Find out more about AmplideX PCR/CE DMPK Kit

View Flyer >

Benefits of AmplideX® PCR/CE DMPK Kit include:

  • Sensitive detection and accurate sizing of CTG repeat expansion in the DMPK gene
  • Detection of very large repeat expansions – up to 2000 repeats
  • PCR-only workflow enables rapid and precise analysis of large repeats, eliminating the need for Southern Blot
  • All-inclusive test kit containing all the necessary reagents to go from sample to result in a single-day workflow

For feedback or more information on this kit

Contact our Product Manager >

Related Products:



Request a Quote

Request Quote

Recent Posts

Devyser Genomic Blood Typing

A streamlined NGS solution for comprehensive blood typing, covering most relevant red blood cell, platelet, and neutrophil antigens in a single assay. Devyser Genomic Blood…

Read full article

Devyser Thalassemia v2

Thalassemia testing. Simplifed. Comprehensive NGS testing for thalassemia and sickle cell disease. Now with β-modifier detection, robust CNV analysis, and a streamlined workflow.Devyser Thalassemia v2…

Read full article

Bio-Techne – QuantideX® JAK2 V617F

Simplified, Sensitive, & Scalable JAK2 V617F Mutation DetectionThe QuantideX® qPCR JAK2 Kit delivers highly sensitive and quantitative detection of the JAK2 V617F mutation relative to…

Read full article